Skip to main content

Advertisement

Log in

Polymorphisms of the macrophage inflammatory protein 1 alpha and ApoE genes are associated with ulcerative colitis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aims

An increased production of macrophage inflammatory proteins 1 alpha (MIP-1α) has been reported to be associated with ulcerative colitis (UC). We investigated whether a polymorphism site in MIP-1α was associated with UC in a Chinese population. Additionally, considering the abnormal lipoprotein metabolism in subjects with UC, we also sought to determine whether genetic variation in the apolipoprotein E (ApoE) gene may play a role in the development of UC.

Materials and methods

We examined the MIP-1α −906 (TA)4/(TA)6 polymorphism and the ApoE polymorphism in a cohort of 162 unrelated UC patients and 220 healthy controls by using restriction fragment length polymorphism assay.

Results

A significantly increased frequency of the MIP-1α −906 (TA)6/(TA)6 genotype (P = 0.0031, odds ratio [OR] = 1.851, 95% confidence interval [CI] 1.228–2.791), as well as of the ApoE ε4+ genotype (P < 0.001, OR = 2.869, 95% CI 1.768–4.657), in patients with UC was proven. Moreover, the carriage of both MIP-1α −906 (TA)6/(TA)6 genotype and ApoE ε4+ genotype confers greater risk for the development of UC (P < 0.001, OR = 5.432, 95% CI 2.761–10.689).

Conclusion

These findings suggest that variation in the MIP-1α and ApoE genes and their interaction may increase susceptibility to UC. Identifying these novel susceptibility genes, as well as their interactions, will help our understanding of the disease mechanisms of UC and may identify targets for developing novel treatment measures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205

    Article  PubMed  CAS  Google Scholar 

  2. Hugot JP, Zouali H, Lesage S, Thomas G (1999) Etiology of the inflammatory bowel diseases. Int J Colorectal Dis 14:2–9

    Article  PubMed  CAS  Google Scholar 

  3. MacDermott RP (1999) Chemokines in inflammatory bowel diseases. J Clin Immunol 5:266–272

    Article  Google Scholar 

  4. Zhong W, Kolls JK, Chen H, McAllister F, Oliver PD, Zhang Z (2008) Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease. Front Biosci 13:1654–1664

    Article  PubMed  CAS  Google Scholar 

  5. Papadakis KA, Targan SR (2000) The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm Bowel Dis 6:303–313

    Article  PubMed  CAS  Google Scholar 

  6. Banks C, Bateman A, Payne R, Johnson P, Sheron N (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn’s disease. J Pathol 199:28–35

    Article  PubMed  CAS  Google Scholar 

  7. Davatelis G, Tekamp-Olson P, Wolpe SD, Hermsen K, Luedke C, Gallegos C, Coit D, Merryweather J, Cerami A (1988) Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties. J Exp Med 167:1939–1944

    Article  PubMed  CAS  Google Scholar 

  8. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV (1993) Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177:1821–1826

    Article  PubMed  CAS  Google Scholar 

  9. Menten P, Wuyts A, Van-Damme DJ (2002) Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13:455–481

    Article  PubMed  CAS  Google Scholar 

  10. Grimm MC, Doe WF (1996) Chemokines in IBD mucosa: expression of RANTES, MIP-1α, MIP-1β and interferon inducible protein 10 by macrophages, lymphocytes, endothelial cells and granulomas. Inflammatory Bowel Dis 2:88–96

    Article  Google Scholar 

  11. Vainer B, Nielsen OH, Horn T (1998) Expression of E-selectin, sialyl Lewis X, and macrophage inflammatory protein-1alpha by colonic epithelial cells in ulcerative colitis. Dig Dis Sci 43:596–608

    Article  PubMed  CAS  Google Scholar 

  12. Ajuebor MN, Kunkel SL, Hogaboam CM (2004) The role of CCL3/macrophage inflammatory protein-1alpha in experimental colitis. Eur J Pharmacol 497:343–349

    Article  PubMed  CAS  Google Scholar 

  13. Al-Sharif FM, Makki RF, Ollier WE, Hajeer AH (1999) A new microsatellite marker within the promoter region of the MIP-1A gene. Immunogenetics 49:740–741

    Article  PubMed  CAS  Google Scholar 

  14. Hagberg JM, Wilund KR, Ferrell RE (2000) APOE gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics 4:101–108

    PubMed  CAS  Google Scholar 

  15. Ripollés Piquer B, Nazih H, Bourreille A, Segain JP, Huvelin JM, Galmiche JP, Bard JM (2006) Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism 55:980–988

    Article  PubMed  CAS  Google Scholar 

  16. Jofre-Monseny L, Loboda A, Wagner AE, Huebbe P, Boesch-Saadatmandi C, Jozkowicz A, Minihane AM, Dulak J, Rimbach G (2007) Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Comm 357:319–324

    Article  PubMed  CAS  Google Scholar 

  17. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6

    Article  PubMed  CAS  Google Scholar 

  18. Wang B, Jin F, Xie Y, Tang Y, Kan R, Zheng C, Yang Z, Wang L (2006) Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer’s disease. Neurosci Lett 409:179–181

    Article  PubMed  CAS  Google Scholar 

  19. Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392:565–568

    Article  PubMed  CAS  Google Scholar 

  20. Luster AD (1998) Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445

    Article  PubMed  CAS  Google Scholar 

  21. MacDermott RP, Sanderson IR, Reinecker HC (1998) The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn’s disease. Inflam Bowel Dis 4:54–67

    CAS  Google Scholar 

  22. Pender SL, Chance V, Whiting CV, Buckley M, Edwards M, Pettipher R, MacDonald TT (2005) Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut 54:1114–1120

    Article  PubMed  CAS  Google Scholar 

  23. Choi SJ, Oba T, Callander NS, Jelinek DF, Roodman GD (2003) AML-1A and AML-1B regulation of MIP-1 alpha expression in multiple myeloma. Blood 101:3778–3783

    Article  PubMed  CAS  Google Scholar 

  24. Broedl UC, Schachinger V, Lingenhel A, Lehrke M, Stark R, Seibold F, Göke B, Kronenberg F, Parhofer KG, Konrad-Zerna A (2007) Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflamm Bowel Dis 13:391–397

    Article  PubMed  Google Scholar 

  25. Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y (1997) Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12:1438–1445

    Article  PubMed  CAS  Google Scholar 

  26. Wong SY, Lau EM, Li M, Chung T, Sham A, Woo J (2005) The prevalence of Apo E4 genotype and its relationship to bone mineral density in Hong Kong Chinese. J Bone Miner Metab 23:261–265

    Article  PubMed  CAS  Google Scholar 

  27. Ulivieri FM, Lisciandrano D, Ranzi T, Taioli E, Cermesoni L, Piodi LP, Nava MC, Vezzoli M, Bianchi PA (2000) Bone mineral density and body composition in patients with ulcerative colitis. Am J Gastroenterol 95:1491–1494

    Article  PubMed  CAS  Google Scholar 

  28. Jofre-Monseny L, Minihane AM, Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52:131–145

    Article  PubMed  CAS  Google Scholar 

  29. Vitek MP, Brown CM, Colton CA (2008) APOE genotype-specific differences in the innate immune response. Neurobiol Aging Dec 20; [Epub ahead of print]

  30. Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT (2003) APOE genotype and an ApoE mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 278:48529–48533

    Article  PubMed  CAS  Google Scholar 

  31. Ophir G, Amariglio N, Jacob-Hirsch J, Elkon R, Rechavi G, Michaelson DM (2005) Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. Neurobiol Dis 20:709–718

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank all the participants and researchers who took participation in the study. This work was supported by a grant from Harbin Engineering University (Project No. HEUFT06007).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Binyou Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, K., Wang, B., Sui, H. et al. Polymorphisms of the macrophage inflammatory protein 1 alpha and ApoE genes are associated with ulcerative colitis. Int J Colorectal Dis 24, 13–17 (2009). https://doi.org/10.1007/s00384-008-0575-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-008-0575-0

Keywords

Navigation